Kristin Fløgstad Degnes

Kristin Fløgstad Degnes

Auto-generated profile, based on publicly available information

Kristin Fløgstad Degnes

SINTEF Industry, Biotechnology and Nanomedicine

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2013 in Marine Drugs
Verified
Journal Article
Open access
PDF file
LMLene E. Myhren
Lene E. Myhren
GNGyrid Nygaard
Gyrid Nygaard
GGGro Gausdal
Gro Gausdal
HSHåvard Sletta
Håvard Sletta
KTKnut Teigen
Knut Teigen
LHLars Herfindal
Lars Herfindal
Despite recent improvement in therapy, acute myeloid leukemia (AML) is still associated with high lethality. In the presented study, we analyzed the bioactive compound iodinin (1,6-dihydroxyphenazine 5,10-dioxide) from a marine actinomycetes bacterium for the ability to induce cell death in a range of cell types. Iodinin showed selective toxicity to AML and acute promyelocytic (APL) leukemia cells, with EC50 values for cell death up to 40 times lower for leukemia cells when compared with normal cells. Iodinin also successfully induced cell death in patient-derived leukemia cells or cell lines with features associated with poor prognostic such as FLT3 internal tandem duplications or mutated/deficient p53. The cell death had typical apoptotic morphology, and activation of apoptotic signaling proteins like caspase-3. Molecular modeling suggested that iodinin could intercalate between bases in the DNA in a way similar to the anti-cancer drug daunorubicin (DNR), causing DNA-strand breaks. Iodinin induced apoptosis in several therapy-resistant AML-patient blasts, but to a low degree in peripheral blood leukocytes, and in contrast to DNR, not in rat cardiomyoblasts. The low activity towards normal cell types that are usually affected by anti-leukemia therapy suggests that iodinin and related compounds represent promising structures in the development of anti-cancer therapy.

2 March 2017 in Food and Bioprocess Technology
Verified
Journal Article
Closed access
PDF file
KDKristin Fløgstad Degnes
Kristin Fløgstad Degnes
HKHans Fredrik Nyvold Kvitvang
Hans Fredrik Nyvold Kvitvang
HHHanne Haslene-Hox
Hanne Haslene-Hox
IAInga Marie Aasen
Inga Marie Aasen

18 June 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
ÓVÓscar Velasco-Rodríguez
Óscar Velasco-Rodríguez
MFMariana Fil
Mariana Fil
Tonje Marita Bjerkan HeggesetTonje Marita Bjerkan Heggeset
Tonje Marita Bjerkan Heggeset
KDKristin F. Degnes
Kristin F. Degnes
DBDavid Becerro-Recio
David Becerro-Recio
Carlos BarreiroCarlos Barreiro
Carlos Barreiro
Rotting wood is inhabited by a large diversity of bacteria, fungi, and insects with complex environmental relationships. The aim of this work was to study the composition of the microbiota (bacteria and fungi) in decaying wood from a northwest Spanish forest as a source of industrially relevant microorganisms. The analyzed forest is situated in a well-defined biogeographic area combining Mediterranean and temperate macrobioclimates. Bacterial diversity, determined by metagenome analyses, was higher than fungal heterogeneity. However, a total of 194 different cultivable bacterial isolates (mainly Bacillaceae, Streptomycetaceae, Paenibacillaceae, and Microbacteriaceae) were obtained, in contrast to 343 fungal strains (mainly Aspergillaceae, Hypocreaceae, and Coniochaetaceae). Isolates traditionally known as secondary metabolite producers, such as Actinobacteria and members of the Penicillium genus, were screened for their antimicrobial activity by the detection of antibiotic biosynthetic clusters and competitive bioassays against fungi involved in wood decay. In addition, the ability of Penicillium isolates to degrade cellulose and release ferulic acid from wood was also examined. These results present decaying wood as an ecologically rich niche and a promising source of biotechnologically interesting microorganisms.

27 August 2016 in Molecules
Verified
Journal Article
Open access
PDF file
OSOlga Sekurova
Olga Sekurova
Ignacio Pérez-VictoriaIgnacio Pérez-Victoria
Ignacio Pérez-Victoria
JSJesús Martín Serrano
Jesús Martín Serrano
KDKristin F. Degnes
Kristin F. Degnes
HSHåvard Sletta
Håvard Sletta
SZSergey Zotchev
Sergey Zotchev
Activation of silent biosynthetic gene clusters in Streptomyces bacteria via overexpression of cluster-specific regulatory genes is a promising strategy for the discovery of novel bioactive secondary metabolites. This approach was used in an attempt to activate a cryptic gene cluster in a marine sponge-derived Streptomyces albus PVA94-07 presumably governing the biosynthesis of peptide-based secondary metabolites. While no new peptide-based metabolites were detected in the recombinant strain, it was shown to produce at least four new analogues of deferoxamine with additional acyl and sugar moieties, for which chemical structures were fully elucidated. Biological activity tests of two of the new deferoxamine analogues revealed weak activity against Escherichia coli. The gene knockout experiment in the gene cluster targeted for activation, as well as overexpression of certain genes from this cluster did not have an effect on the production of these compounds by the strain overexpressing the regulator. It seems plausible that the production of such compounds is a response to stress imposed by the production of an as-yet unidentified metabolite specified by the cryptic cluster.

27 January 2026 in Applied and Environmental Microbiology
Verified
Journal Article
Open access
KDKristin Fløgstad Degnes
Kristin Fløgstad Degnes
ANAnna Nordborg
Anna Nordborg
GNGiang-Son Nguyen
Giang-Son Nguyen
GNGuro Kruge Nærdal
Guro Kruge Nærdal
Tonje Marita Bjerkan HeggesetTonje Marita Bjerkan Heggeset
Tonje Marita Bjerkan Heggeset
HSHåvard Sletta
Håvard Sletta
A novel compound denoted MBL-AB01 was isolated from a marine Actinoalloteichus , which belongs to a rare and underexplored class of Actinobacteria . This work demonstrates that the novel compound MBL-AB01 shows very high activity in vitro against six methicillin-resistant Staphylococcus aureus strains, and high activity against a panel of three other Gram-positive strains, including a vancomycin-resistant Enterococcus faecium . Structure elucidation of the compound revealed that MBL-AB01 is a polycyclic xanthone antibiotic closely related to the bioactive compounds: xantholipin and lysolipin. This class of antibiotics has caught interest due to its unique chemical structure and diverse biological activity. The gene cluster encoding MBL-AB01 production was identified, and the individual genes within the cluster were annotated along with proposed functional roles. The compound was produced by bioreactor fermentations, and significantly higher yields of MBL-AB01 were obtained after classical mutagenesis and fermentation process improvements. IMPORTANCE: Methicillin-resistant Staphylococcus aureus (MRSA) infections have become a great challenge in hospitals over the last decades, and MRSA is currently one of the six pathogens on the World Health Organization priority list. Here, we demonstrate that the novel antibiotic MBL-AB01 has excellent antibacterial properties against six S. aureus strains, including MRSA. MBL-AB01 belongs to the poorly explored class of polycyclic xanthones, thereby fulfilling innovation criteria for the development of new antibiotics. The compound can be produced in sufficient amounts for early formulation development and pre-clinical trials.

20 May 2026
Verified
Dataset
Closed access
KDKristin Degnes
Kristin Degnes
GKGeir Klinkenberg
Geir Klinkenberg
SFSantiago Fragosos
Santiago Fragosos
BLBruno Emanuel Pereira Louro
Bruno Emanuel Pereira Louro
CCCymon J. Cox
Cymon J. Cox